Generic Drugs

All NCCN Cancer Centers Report Anti-Cancer Drug Shortages

The survey shows generics such as ifosfamide, carboplatin and BCG are in short supply, prompting altered dosing, clinical trial disruptions, policy demands for manufacturing incentives, clearer supplier data, tariff relief